• 1
    Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh. 2004; 36: 197-206.
  • 2
    Gonzalez J, Gilbert MR. Treatment of astrocytomas. Curr Opin Neurol. 2005; 18: 632-638.
  • 3
    Butler JM, Rapp SR, Shaw EG. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol. 2006; 7: 517-523.
  • 4
    Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol. 1996; 30: 61-69.
  • 5
    Brown PD, Jensen AW, Felten SJ, et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol. 2006; 24: 5427-5433.
  • 6
    Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998; 280: 1485-1489.
  • 7
    Taylor BV, Buckner JC, Cascino TL, et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol. 1998; 16: 2195-2201.
  • 8
    Kiecolt-Glaser JK, Page GG, Marucha PT, MacCallum RC, Glaser R. Psychological influences on surgical recovery. Perspectives from psychoneuroimmunology. Am Psychol. 1998; 53: 1209-1218.
  • 9
    Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999; 80: 880-888.
  • 10
    Page GG, Ben-Eliyahu S. The immune-suppressive nature of pain. Semin Oncol Nurs. 1997; 13: 10-15.
  • 11
    Chang VT, Hwang SS, Feuerman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 2000; 88: 1175-1183.
  • 12
    Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001; 28: 465-470.
  • 13
    Lobchuk MM. The memorial symptom assessment scale: modified for use in understanding family caregivers' perceptions of cancer patients' symptom experiences. J Pain Symptom Manage. 2003; 26: 644-654.
  • 14
    Sherwood P, Given B, Given C, Schiffman R, Murman D, Lovely M. Caregivers of persons with a brain tumor: a conceptual model. Nurs Inq. 2004; 11: 43-53.
  • 15
    Sherwood PR, Given BA, Given CW, et al. Predictors of distress in caregivers of persons with a primary malignant brain tumor. Res Nurs Health. 2006; 29: 105-120.
  • 16
    Pickard AS, Knight SJ. Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives. Med Care. 2005; 43: 493-499.
  • 17
    Sneeuw KC, Aaronson NK, Osoba D, et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care. 1997; 35: 490-506.
  • 18
    Moinpour CM, Lyons B, Schmidt SP, Chansky K, Patchell RA. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases. Qual Life Res. 2000; 9: 219-231.
  • 19
    Brown PD, Decker PA, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol. 2008; 31: 163-168.
  • 20
    Lobchuk MM, Degner LF. Symptom experiences: perceptual accuracy between advanced-stage cancer patients and family caregivers in the home care setting. J Clin Oncol. 2002; 20: 3495-3507.
  • 21
    Lobchuk MM, Degner LF. Patients with cancer and next-of-kin response comparability on physical and psychological symptom well-being: trends and measurement issues. Cancer Nurs. 2002; 25: 358-374.
  • 22
    Chatterjee A, Anderson KE, Moskowitz CB, Hauser WA, Marder KS. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. J Neuropsychiatry Clin Neurosci. 2005; 17: 378-383.
  • 23
    Lobchuk MM, McClement SE, Daeninck PJ, Shay C, Elands H. Asking the right question of informal caregivers about patient symptom experiences: multiple proxy perspectives and reducing interrater gap. J Pain Symptom Manage. 2007; 33: 130-145.
  • 24
    Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000; 89: 1634-1646.
  • 25
    Armstrong TS, Mendoza T, Gning I, et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006; 80: 27-35.
  • 26
    Benedict RH, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol. 1998; 20: 339-352.
  • 27
    Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004; 19: 203-214.
  • 28
    Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 1997.
  • 29
    SPSS Incorporated. PASW Statistics [computer program]. Version 17.0.2. Chicago, IL: SPSS; 2009.
  • 30
    Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277-284.
  • 31
    Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85: 1186-1196.
  • 32
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
  • 33
    Armstrong TS, Vera-Bolanos E, Gning I, et al. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011; 117: 32223228.
  • 34
    Armstrong TS, Gning I, Mendoza TR, et al. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage. 2009; 37: 331-340.
  • 35
    Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010; 116: 2707-2715.
  • 36
    Sloan J, Symonds T, Vargas-Chanes D, Fridley B. Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Inf J. 2003; 37: 23-31.
  • 37
    Sloan JA, Vargas-Chanes D, Kamath CC, et al. Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. J Cancer Integr Med. 2003; 1: 41-47.
  • 38
    Zhang AY, Siminoff LA. Silence and cancer: why do families and patients fail to communicate? Health Commun. 2003; 15: 415-429.
  • 39
    Zhang AY, Siminoff LA. The role of the family in treatment decision making by patients with cancer. Oncol Nurs Forum. 2003; 30: 1022-1028.
  • 40
    Lobchuk MM, McClement SE, Daeninck PJ, Elands H. Caregiver thoughts and feelings in response to different perspective-taking prompts. J Pain Symptom Manage. 2007; 33: 420-433.
  • 41
    Lobchuk MM, Degner LF, Chateau D, Hewitt D. Promoting enhanced patient and family caregiver congruence on lung cancer symptom experiences. Oncol Nurs Forum. 2006; 33: 273-282.
  • 42
    Lobchuk MM, Vorauer JD. Family caregiver perspective-taking and accuracy in estimating cancer patient symptom experiences. Soc Sci Med. 2003; 57: 2379-2384.
  • 43
    Batson CD, Early S, Salvarani G. Perspective-taking: imagining how another feels versus imagining how you would feel. Pers Soc Psychol Bull. 1997; 23: 751-758.